The transcription of NEAT1 is primarily regulated by hypoxia-inducible factor-2, and the overexpression of NEAT1 can accelerate cell proliferation and inhibit apoptosis (18). The prognosis of patients
YIQUAN XIONG,ZEMING LIU,LI ZHI,SHUNTAO WANG,NA SHEN,YUE XIN,TAO HUANG
2019-01-01
Abstract:Previous studies revealed that the long non-coding RNA nuclear paraspeckle assembly transcript 1 (NEAT1) exhibits abnormal expression in numerous cancer types, including breast cancer (BC); however, the regulatory mechanism of NEAT1 in BC remains unclear. In the present study, the effect of NEAT1 on the progression of BC and its regulation mechanism was investigated. The expression levels of NEAT1 and microRNA-107 (miR-107) in BC cells were analyzed using the reverse transcription-quantitative polymerase chain reaction (RT-qPCR). NEAT1 was knocked down in BC cells, and mimics-miR-107 or inhibitor-miR-107 were transfected into BC cells. Subsequently, cell proliferation, invasion and migration, apoptosis and cell cycle distribution were determined. The regulatory mechanism of NEAT1, miR-107 and carnitine palmitoyltransferase-1 (CPT1A) was analyzed using a luciferase reporter assay system, western blotting and RT-qPCR. NEAT1 expression was increased in BC cells, whereas miR-107 expression was decreased, compared with normal mammary gland cells. NEAT1 promoted the progression of BC cells through inhibiting apoptosis-associated genes and promoting cell cycleand invasion-associated gene expression, whereas miR-107 served the opposite function. Furthermore, NEAT1 promoted the expression of CPT1A, which was mediated by miR-107. The results of the present study indicate that NEAT1 promotes the expression of CPT1A by inhibiting miR-107 to improve the progression of BC cells; therefore, NEAT1 is a potential therapeutic target of BC. Introduction Breast cancer (BC) is a malignant tumor that occurs in the epithelial tissue of the mammary gland and was the most common cancer type among women globally (1). In China, in 2015, 272,400 novel BC cases were identified with a mortality toll of 70,700 in 2015 (2). In the USA, in 2016, the number of novel cases and mortalities of BC were 249,260 and 40,890, respectively (3). Although the combined treatment of surgery, radiotherapy, chemotherapy, endocrine therapy and targeted therapy has achieved good clinical results, recurrence and metastasis remain the primary factors affecting survival (4). Non-coding RNAs, which do not encode protein, may be classified as short non‐coding RNAs, including microRNAs (miRNAs), and long non-coding RNAs (lncRNAs), for example, HOTAIR, H19 and MALAT1 have been widely studied (5). These RNAs bind to specific sequences to degrade the transcription of target genes (5). Previous studies confirmed that lncRNAs serve important functions in numerous biological processes, including guiding chromosome remodeling and regulating miRNAs (6-9). Compared with normal tissues, cancer tissues exhibit abnormal expression of lncRNAs (10). Increasing evidence demonstrated that a high level of the lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1) is associated with unfavorable prognosis in BC (11,12). NEAT1 is located at nuclear paraspeckles to form and maintain their structure (13,14). The stabilization of paraspeckles can interrupt mRNA, which is retained in paraspeckles and translated into protein, regulating the expression of target genes accurately and rapidly (15,16). NEAT1 is upregulated prominently in hypoxia-regulated BC cells (17). The transcription of NEAT1 is primarily regulated by hypoxia-inducible factor-2, and the overexpression of NEAT1 can accelerate cell proliferation and inhibit apoptosis (18). The prognosis of patients with BC with high expression of NEAT1 is significantly decreased, compared with patients with low NEAT1 expression (19). Further studies indicated that NEAT1 combines with miR-107 and downregulates its expression level to promote the progression of numerous human cancer types, including glioma and laryngeal squamous cell cancer (20,21). A number of studies have identified that miR‐107 serves a significant function in the development and progression of Long non‐coding RNA nuclear paraspeckle assembly transcript 1 interacts with microRNA‐107 to modulate breast cancer growth and metastasis by targeting carnitine palmitoyltransferase‐1 YIQUAN XIONG*, ZEMING LIU*, ZHI LI, SHUNTAO WANG, NA SHEN, YUE XIN and TAO HUANG Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China Received February 8, 2018; Accepted February 28, 2019 DOI: 10.3892/ijo.2019.4869 Correspondence to: Dr Tao Huang, Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Road, Wuhan, Hubei 430022, P.R. China E-mail: huangtao180117@sina.com *Contributed equally